GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGD) » Definitions » Common Stock

PSYGD (Psyence Group) Common Stock : $15.29 Mil (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Common Stock?

Psyence Group's quarterly common stock increased from Jun. 2024 ($15.89 Mil) to Sep. 2024 ($16.08 Mil) but then declined from Sep. 2024 ($16.08 Mil) to Dec. 2024 ($15.29 Mil).

Psyence Group's annual common stock increased from Mar. 2022 ($12.66 Mil) to Mar. 2023 ($14.91 Mil) and increased from Mar. 2023 ($14.91 Mil) to Mar. 2024 ($16.00 Mil).


Psyence Group Common Stock Historical Data

The historical data trend for Psyence Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Common Stock Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Common Stock
6.32 6.50 12.66 14.91 16.00

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.27 16.00 15.89 16.08 15.29

Psyence Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines